My Natural Treatment

Warning LetterOpen

Andreea Laza My Natural Treatment Romania contact@mynaturaltreatment.comIssued Feb 22, 2022Center for Drug Evaluation and Research | CDER

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations0

Issue DateFeb 22, 2022

Product TypeDrugs

StatusOpen

Letter Details

Firm: My Natural Treatment
Location: Andreea Laza My Natural Treatment Romania contact@mynaturaltreatment.com
FEI Number: N/A
Country: Romania
Issue Date: February 22, 2022
Issuing Office: Center for Drug Evaluation and Research | CDER
Product Type: Drugs
Status: Open

Summary

My Natural Treatment was cited for marketing unapproved new drugs and misbranded products related to COVID-19 treatment and prevention, specifically thyme, black seed, eucalyptus, rosemary, and peppermint oil products sold through their website and Amazon Associates program. The company made claims that these products could mitigate, prevent, treat, diagnose, or cure COVID-19 in people, causing them to be classified as unapproved drugs under section 505(a) of the Federal Food, Drug, and Cosmetic Act and misbranded drugs under section 502. The FDA and FTC jointly reviewed the company's website and social media platforms and determined that introducing these products into interstate commerce violated multiple provisions of the FD&C Act, including sections 301(a), 301(d), and 301(k).

My Natural Treatment FDA Warning Letter, February 22, 2022